Ani Pharmaceuticals (ANIP) Long-Term Investments (2010 - 2013)

Ani Pharmaceuticals has disclosed Long-Term Investments across 4 years of filings, most recently posting $3.4 million for Q1 2013.

• In Q1 2013, Long-Term Investments changed 0.0% year-over-year to $3.4 million; the TTM figure through Mar 2013 stood at $3.4 million (changed 0.0% YoY), while the FY2012 annual figure was $3.4 million, changed 0.23% from the prior year.
• Long-Term Investments came in at $3.4 million for Q1 2013 at Ani Pharmaceuticals, roughly flat from $3.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $3.4 million in Q1 2012 to a low of $3.4 million in Q4 2010.
• Average Long-Term Investments over 4 years is $3.4 million, with a median of $3.4 million recorded in 2012.
• Year-over-year, Long-Term Investments changed 0.0% in 2011 and advanced 0.23% in 2012.
• Over 4 years, Long-Term Investments stood at $3.4 million in 2010, then changed by 0.0% to $3.4 million in 2011, then increased by 0.23% to $3.4 million in 2012, then changed by 0.0% to $3.4 million in 2013.
• Per Business Quant data, the three most recent Long-Term Investments figures were $3.4 million in Q1 2013, $3.4 million in Q4 2012, and $3.4 million in Q3 2012.